Document an ABA Functional Analysis and Safety Limits

To document an ABA experimental functional analysis and its safety boundaries, record why an experimental comparison is needed, who is qualified and authorized, and which less risky evidence was considered. Define consent and assent when applicable, conditions, programmed events, response and integrity measures, staff roles, medical and environmental prerequisites, stop and emergency rules, deviations, client experience, results, uncertainty, and the qualified clinical decision that follows.

Define Keiko's experimental functional-analysis record

Keiko treats a functional analysis as a deliberately arranged clinical assessment with potential risk, never as a routine trial inserted into ordinary service. The record links every condition to its rationale and identifies actions that staff may and may not take. The record names the assessment question, source, client priority, period, setting, accessible communication, ordinary supports, clinical purpose, qualified decision owner, known risk, open uncertainty, and evidence required before a claim or decision can move forward.

Build Keiko's page-specific fields

Keiko records referral question, client priorities, target definition, clinical rationale, alternatives considered, qualified lead, setting authority, legal consent, assent process when applicable, individualized willingness and withdrawal signals, AAC and backup, health review, contraindications, emergency contacts, condition names, programmed antecedents and consequences, control condition, sequence and schedule, staff assignments, training, protective equipment when applicable, response measure, integrity measure, stop threshold, session termination, event review, treatment outside analysis, client experience, deviations, raw data, graph, interpretation, ambiguity, recommendation, notification, correction, and follow-up. Any unplanned restrictive action follows its own authority and incident route.

Keiko prepares a condition card for every planned session. It names the materials, people, access supports, programmed events, response definition, measurement window, integrity steps, stop threshold, and immediate action after a stop. The card also identifies which event would make the session invalid and which deviation a qualified reviewer may still interpret. Staff rehearse roles without evoking the target event and demonstrate emergency communication before release. After each session, the lead records actual conditions and deviations before viewing the aggregate graph. This reduces retrospective relabeling and lets safety, integrity, and outcome evidence be reviewed on their own terms.

Make Keiko's assessment record usable during care

Keiko gives each role the current question, method, safety rules, communication supports, and evidence status at the point of work. The workflow distinguishes planned, collected, missing, invalid, declined, stopped, under review, corrected, and closed evidence. Original reports and observations remain intact while qualified interpretation, corrections, and downstream decisions receive separate authorship and dates.

Keep client access and clinical authority visible for Keiko

Keiko preserves direct client communication, AAC, ordinary supports, consent and assent when applicable, dissent, withdrawal, privacy, health, safety, priorities, burden, and choice. Administrative staff and software can route work, calculate defined measures, and flag inconsistency. An appropriately qualified and authorized professional selects methods, interprets clinical evidence, determines referrals, and makes case-specific recommendations within scope.

Work through Keiko's fictional example

Keiko schedules 12 analysis sessions after all release gates clear. Ten run as designed. One stops when the individualized withdrawal signal occurs, and one stops at a predeclared health threshold. Eight of the ten completed sessions meet every condition-integrity component; two contain deviations and remain interpretable only after qualified review. Stopped sessions remain in safety reporting and outside completed-condition calculations. These numbers teach evidence structure and denominator discipline. They do not establish diagnosis, behavioral function, treatment effect, medical necessity, payer approval, legal compliance, or a universal assessment standard.

Keep Keiko's measures honest

Planned-session completion is 10 of 12, or 83.3%. Complete implementation integrity is 8 of 10 completed sessions, or 80.0%. Response patterns, stop events, deviations, injuries, client experience, and clinical interpretation each use separate counts and denominators.

Address Keiko's main assessment risk

Recreating severe events can exceed the information value of the assessment. Keiko continually weighs the question, existing evidence, safer alternatives, client signals, current risk, and whether further exposure remains justified.

Test Keiko's record against hard cases

Keiko tests missing consent, changed assent, unavailable AAC, health concern, staff substitution, condition error, equipment failure, response threshold, emergency event, ambiguous pattern, early termination, and a recommendation to stop the analysis.

Review Keiko's decision handoff

Keiko confirms the active question, client priorities, source and author, method and setting, access, observation and opportunity boundaries, prompts and supports, raw counts, missing and invalid states, health and safety, client communication, hypothesis and alternatives, qualified interpretation, recommendation or referral, correction route, recipients, unresolved work, owner, and next review date before the assessment affects a plan, service, payer package, disclosure, or public claim.

Scope Keiko's assessment authority and sources

Keiko uses the CASP Version 3.0 public summary only for high-level individualized assessment and treatment-planning scope for ABA treatment of people diagnosed with autism. The detailed guidelines require a license. The current BACB Ethics Code applies to covered people and addresses competence, understandable communication, client involvement, consent and assent when applicable, medical needs, assessment, risk, documentation, referral, and evaluation. BACB has no separate organizational jurisdiction.

Use Keiko's assessment outline as education

Keiko uses the BCBA Test Content Outline, 6th edition for examination-content concepts such as record review, interviews, direct observation, descriptive assessment, functional analysis, cultural variables, referral, client-informed goals, measurement, risk, and data-based decisions. It is not a case protocol, license, payer rule, legal authority, or universal order of methods.

Keep Keiko's functional claims within evidence limits

Keiko uses Hanley's functional-assessment review to frame assessment as a broader evidence process and the Hanley, Iwata, and McCord review for historical experimental functional-analysis context. Neither source makes an interview prediction, descriptive co-occurrence, one experimental condition, or an out-of-context result universal proof for another client.

Interpret Keiko's indirect evidence cautiously

Keiko uses the small Saini interview study, Dracobly FAST comparison, and Scheithauer caregiver-report study as examples of agreement and disagreement across particular methods and cases. Their samples, denominators, tools, and settings do not create universal accuracy rates or a hierarchy in which client, caregiver, staff, direct-observation, or experimental evidence automatically wins.

Protect Keiko's client communication and safety

Keiko treats the Breaux and Smith assent paper as practice guidance from an evolving evidence base rather than a separate BACB mandate. ASHA's AAC portal says AAC users should always have access to their tools or devices. SAMHSA's crisis page routes danger or medical emergency in the United States to 911 or the nearest emergency room. Local systems govern elsewhere, and routine assessment review never delays urgent action.

Choose Keiko's next review trigger

Keiko reopens the experimental functional-analysis record when the question, client priority, authority, consent, assent, communication method, health status, definition, method, setting, support, staff role, source, hypothesis, safety rule, recommendation, payer use, correction, missingness pattern, or audit finding changes. The record preserves the prior version and identifies the new evidence, effective date, affected work, communication, owner, and validation.

Close Keiko's assessment record with its limits visible

Review the experimental functional-analysis record with the client and authorized people as applicable, qualified clinicians, and the specialists named in the manifest. Confirm the question, access, authority, sources, observations, safety, uncertainty, alternatives, interpretation, decision, correction, and downstream use. Keep unresolved evidence visible and keep this page draft and noindex until every required external review is complete.

Document an ABA Experimental Functional Analysis and Its Safety Boundaries